• One Health
  • Pain Management
  • Oncology
  • Anesthesia
  • Geriatric & Palliative Medicine
  • Ophthalmology
  • Anatomic Pathology
  • Poultry Medicine
  • Infectious Diseases
  • Dermatology
  • Theriogenology
  • Nutrition
  • Animal Welfare
  • Radiology
  • Internal Medicine
  • Small Ruminant
  • Cardiology
  • Dentistry
  • Feline Medicine
  • Soft Tissue Surgery
  • Urology/Nephrology
  • Avian & Exotic
  • Preventive Medicine
  • Anesthesiology & Pain Management
  • Integrative & Holistic Medicine
  • Food Animals
  • Behavior
  • Zoo Medicine
  • Toxicology
  • Orthopedics
  • Emergency & Critical Care
  • Equine Medicine
  • Pharmacology
  • Pediatrics
  • Respiratory Medicine
  • Shelter Medicine
  • Parasitology
  • Clinical Pathology
  • Virtual Care
  • Rehabilitation
  • Epidemiology
  • Fish Medicine
  • Diabetes
  • Livestock
  • Endocrinology

Veterinary Startup Dr. Treat Readies Second California Location

News
Article

Dr. Treat Anticipates Opening Its Burlingame Clinic in January 2024

Pixel-Shot/stock.adobe.com

Pixel-Shot/stock.adobe.com

Dr. Treat will open a location in Burlingame, Calif., in January 2024. Dr. Treat's goal is simple: Focus on wellness rather than illness and provide proactive and preventive care to help animals live longer, healthier and happier lives.

The opening of a second Dr. Treat clinic in January 2024 represents a significant milestone for the company. Dr. Treat’s flagship clinic on Union Street in San Francisco celebrated its first anniversary earlier this year. Access to Dr. Treat’s services are available through a membership. This membership allows members to get unlimited access to the clinic and Telehealth platform annually. Clients are able to use the Dr. Treat mobile app for all of their pet’s care needs, including booking, canceling or rescheduling appointments, accessing digitized pet medical records in real time, requesting refills on prescriptions, or communicating with the Dr. Treat team and doing Telehealth appointments, among other actions.

Dr. Treat’s goal is to leverage technology and data to create individualized treatment plans designed around each pet’s unique needs and characteristics. To that end, Dr. Treat has built its own Patient Information Management Software to make it easy and seamless for its teams to offer the highest quality of care, consistently

Dr. Treat’s clinics are built to fear-free standards to create a low anxiety environment for pets. Both clinics offer a reduced-stress environment to pets, pet parents and the veterinary care team in a ‘state of the heart’ environment. Additionally, all members of the Dr. Treat team are Fear-Free certified. Both clinics offer state-of-the-art surgical, diagnostic, and dental equipment onsite, as well as a pharmacy. The San Francisco clinic was recently named 1 of 5 Merit winners in dvm360's 2023 Hospital Design Competition.

"We are building one of the most technologically advanced veterinary care companies and creating aesthetically designed spaces for anxiety-free experiences,” said Rakesh Tondon, co-founder and CEO of Dr. Treat. “Our goal is to provide best-in-class quality of care for pets and an amazing experience for pet parents, while also driving down costs through the use of technology.”

In 2022, Dr. Treat received $10.5M in seed capital from many Silicon Valley-based investors who recognized the potential of the company's tech-focused approach to veterinary care. The funding round was led by Y Combinator, Liquid2, Epic Ventures, Quarry Ventures, Builders VC, Garuda Ventures, Scrum Ventures, UpHonest Capital and the Rebel Fund, among others. In addition, Dr. Treat had significant interest from animal lovers and angel investors, including Ben Silbermann (Founder/CEO of Pinterest), Divesh Makan (Founder/CEO of ICONIQ Capital), Ravi Sajwan (COO of 5 Hour Energy), Mick Murray (ex-CFO of Blue Cross) and Caterina Fake (Founder of Flickr), among others.

Dr. Treat’s Burlingame clinic will open at 220 Primrose Rd. in late January 2024. For more information, visit Dr. Treat's website.

© 2024 MJH Life Sciences

All rights reserved.